Univest
Univest
  • Markets

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price Near All-Time High as Stock Trades at Rs 1,639.95

  • November 18, 2026
  • Posted by: Chaitanya Auti
  • Category: News
No Comments
SYMBIOTEC Share Price
SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) share price is trading within 2% of its all-time high today and stood at Rs 1,639.95, up 2.39% from the previous close. Market cap was Rs 10,079.21 crore.

SYMBIOTEC Share Price is Rs 1,639.95, up 2.39%, and trading near its peak as market capitalisation stands at Rs 10,079.21 crore.

SYMBIOTEC Share Price is in focus after the stock traded at Rs 1,639.95, up Rs 38.25 from the previous close of Rs 1,601.7, with a 2.39% gain as of 18 November 2026 at 11:23:41 AM IST. The move keeps SYMBIOTEC Share Price near its peak range for this market session, while market capitalisation stands at Rs 10,079.21 crore. For readers tracking SYMBIOTEC Share Price Today, the latest Univest data confirms the price event but does not establish a company-specific catalyst. Even so, SYMBIOTEC Stock News is drawing attention because the price is holding close to its recent high zone, with the day’s range stretching from Rs 1,585.2 to Rs 1,640. The broader question for investors is not only where the stock trades, but how that level compares with its healthcare valuation, earnings metrics and industry peers.

SYMBIOTEC Share Price Today matters because the stock opened at Rs 1,593.55 and moved higher through the morning to Rs 1,640. The latest Univest figures show a gap between the previous close and the current price that is visible in the session move, but they do not assign a reason. For anyone following SYMBIOTEC Share Price Live, the key context is that the stock is trading close to the upper end of the day’s band and close to a market level that has attracted search interest around SYMBIOTEC Share Price Update and SYMBIOTEC Latest News. The next sections place that move inside the company’s fundamentals, Healthcare sector benchmark and peer set.

Table of Contents

Toggle
  • SYMBIOTEC Share Price Today: Price Action Analysis
  • SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching SYMBIOTEC
  • About SYMBIOTEC
  • Frequently Asked Questions
    • What is SYMBIOTEC Share Price today?
    • Why is SYMBIOTEC Share Price in focus?
    • What is the market capitalisation of SYMBIOTEC?
    • How does SYMBIOTEC compare on valuation?
    • What do SYMBIOTEC ROE and ROCE show?
    • What is SYMBIOTEC EPS and book value?
    • Which sector and industry does SYMBIOTEC belong to?
    • How should readers track SYMBIOTEC Share Price on Univest?
  • Track SYMBIOTEC Share Price on Univest

SYMBIOTEC Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,639.95
Previous Close Rs 1,601.7
Today's Move +Rs 38.25 (+2.39%)
Open Rs 1,593.55
High Rs 1,640
Low Rs 1,585.2
Market Capitalisation Rs 10,079.21 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,639.95 versus the previous close of Rs 1,601.7, a rise of 2.39%. The stock opened at Rs 1,593.55, reached a high of Rs 1,640 and touched a low of Rs 1,585.2.

SYMBIOTEC Share Price Today shows a firm session so far, with the stock last traded at Rs 1,639.95 after opening at Rs 1,593.55 and touching an intraday high of Rs 1,640. The intraday low was Rs 1,585.2, so the price has stayed in the upper part of the range through the morning. Compared with the previous close of Rs 1,601.7, the stock is higher by Rs 38.25, or 2.39%. That makes the move important for anyone searching SYMBIOTEC Share Price, SYMBIOTEC Share Price Today or SYMBIOTEC Stock News, because the stock is trading close to its recent peak area without any need to infer a separate trigger. The latest Univest data confirms the price event, while the session range and the gap to the previous close provide the factual backdrop for SYMBIOTEC Share News and SYMBIOTEC Share Price Update.

From a market-news lens, SYMBIOTEC Share Price is one of the names drawing attention in Stocks in News and Market Movers because it is holding close to the morning high. For readers scanning Share Market Today, the key facts are simple: the stock is above its previous close, above its open and close to the top of the day’s range. That is the relevant price action picture for SYMBIOTEC NSE and SYMBIOTEC BSE followers, and it sets up the deeper valuation and sector review below.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis

Metric Value
Market Capitalisation Rs 10,079.21 crore
P/E Ratio 93.65x
P/B Ratio 7.56x
ROE 11.22%
ROCE 12.41%
EPS Rs 17.1
Book Value Per Share Rs 211.8
Dividend Yield 0%

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P/E 93.65x, P/B 7.56x, ROE 11.22%, ROCE 12.41%. These figures provide context only and are not a buy or sell signal.

SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 10,079.21 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 93.65x, P/B at 7.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 211.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 93.65x
Benchmark Median P/E 31.01x
Benchmark Average P/E 58.7x
Benchmark P/E Range 2.75x to 1,425.63x
Company P/B Ratio 7.56x
Benchmark Median P/B 2.88x
Company ROE 11.22%
Benchmark Median ROE 11.33%
Company ROCE 12.41%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 10,079.21 crore
Benchmark Median Market Cap Rs 791.38 crore

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 93.65x, which is above the benchmark median of 31.01x, a difference of +202%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is below the benchmark median of 11.33%, a difference of -0.97%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 13.1%, a difference of -5.27%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,47,943.84 40.92 5.03 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,94,962.14 87.74 16.4 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,78,390.62 83.65 9.67 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,19,789.92 94.36 20.86 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,603.21 28.7 4.31 19.69 21.39

SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P/E ratio of 93.65x compared with the displayed peer median of 83.65x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 10,079.21 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching SYMBIOTEC

  • SYMBIOTEC Share Price is Rs 1,639.95, which is above the previous close of Rs 1,601.7 by Rs 38.25, or 2.39%.
  • SYMBIOTEC Share Price Today is near the session high of Rs 1,640 after opening at Rs 1,593.55.
  • SYMBIOTEC Market Cap stands at Rs 10,079.21 crore, above the industry benchmark median of Rs 791.38 crore.
  • SYMBIOTEC Fundamental Analysis shows a P/E of 93.65 and a P/B of 7.56.
  • SYMBIOTEC Share Price sits in a peer group where its P/E is higher than several listed healthcare names and close to Laurus Labs Ltd.

About SYMBIOTEC

SYMBIOTEC PHARMALAB LTD operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The stock is tracked on NSE and BSE under the symbol SYMBIOTEC. For readers following SYMBIOTEC Share Price, the company is part of the same industry benchmark used in this article, and its market capitalisation, valuation ratios and earnings metrics provide the main factual framework for SYMBIOTEC Stock News and SYMBIOTEC Company News. Univest uses these figures to present a structured view of the stock’s position inside the industry set.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.

Frequently Asked Questions

What is SYMBIOTEC Share Price today?

Ans. SYMBIOTEC Share Price is Rs 1,639.95 as of 18 November 2026 at 11:23:41 AM IST. It is up 2.39% from the previous close of Rs 1,601.7 and remains near the session high.

Why is SYMBIOTEC Share Price in focus?

Ans. SYMBIOTEC Share Price is in focus because it is trading near its peak for the current session, with the day’s high at Rs 1,640 and market capitalisation at Rs 10,079.21 crore.

What is the market capitalisation of SYMBIOTEC?

Ans. SYMBIOTEC has a market capitalisation of Rs 10,079.21 crore. That is above the same-industry median of Rs 791.38 crore and below the benchmark average of Rs 14,698.18 crore.

How does SYMBIOTEC compare on valuation?

Ans. SYMBIOTEC Share Price is backed by a P/E ratio of 93.65 and a P/B ratio of 7.56. Both are above the same-industry median and average, which places the stock at a premium to many peers.

What do SYMBIOTEC ROE and ROCE show?

Ans. SYMBIOTEC reports ROE of 11.22% and ROCE of 12.41%. ROE is close to the industry median, while ROCE is near the industry average, giving useful context for SYMBIOTEC Share Price analysis.

What is SYMBIOTEC EPS and book value?

Ans. EPS is 17.1 and book value is 211.8. EPS shows earnings attributable to each share, while book value shows accounting net worth per share, both of which help frame SYMBIOTEC Share Price.

Which sector and industry does SYMBIOTEC belong to?

Ans. SYMBIOTEC belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That industry benchmark is the right comparison set for reading SYMBIOTEC Share Price, valuation ratios and profit-return metrics.

How should readers track SYMBIOTEC Share Price on Univest?

Ans. Readers can track SYMBIOTEC Share Price on Univest for live price updates, valuation ratios, sector context, peer comparison and stock news. The page brings the latest market view and company-level metrics together.

Track SYMBIOTEC Share Price on Univest

Use SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track SYMBIOTEC Share Price on Univest for live price updates, key financial ratios, market capitalisation, peer comparison, sector context and company-level market insights. Univest also helps readers follow SYMBIOTEC Share Price Today, SYMBIOTEC Latest News and other stock analysis pages in one place. If you are monitoring SYMBIOTEC Stock News, this page keeps the latest market view together with relevant valuation and industry context.



Leave a Reply Cancel reply